Butallylonal

Structural formula
Structural formula without stereochemistry
General
Non-proprietary name	Butallylonal
other names	( RS ) -5- (2-bromoallyl) -5- sec -butylbarbituric acid
Molecular formula	C 11 H 15 BrN 2 O 3
Brief description	Crystals with a slightly bitter taste
External identifiers / databases
CAS number 1142-70-7 3486-86-0 (sodium salt) EC number 214-537-5 ECHA InfoCard 100.013.215 PubChem 14362 Wikidata Q1017842
Drug information
Drug class	sedative
properties
Molar mass	303,15 g · mol -1
Physical state	firmly
Melting point	130-133 ° C
solubility	soluble in ethanol
safety instructions
GHS hazard labeling no classification available
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Butallylonal is a barbiturate . From a chemical point of view, it is a racemate made up of two barbituric acid enantiomers. It was developed in the 1960s and mainly used in veterinary medicine, but currently there are no more preparations based on butallylonal; it has been completely replaced by pentobarbital .

Stereochemistry

Butallylonal has a stereogenic center in the side chain of the heterocyclic ring . Butallylonal is chiral , there is an ( R ) form and an ( S ) form, which are present in a ratio of 1: 1, i.e. represent a racemate .

Legal status

Butallylonal is a marketable and prescription narcotic drug in the Federal Republic of Germany due to its listing in Appendix 3 BtMG. Handling without permission or prescription is generally punishable. Further information can be found in the main article Narcotics Law in Germany .

Internationally, butallylonal falls under the Convention on Psychotropic Substances .

Individual evidence

1. ↑ ^{a b} F.v. Bruchhausen, Siegfried Ebel, AW Frahm, E. Hackenthal: Hager's handbook of pharmaceutical practice substances AD . Springer-Verlag, 2013, ISBN 978-3-642-57995-0 , pp. 516 ( limited preview in Google Book search).
2. ^ William M. Haynes: CRC Handbook of Chemistry and Physics, 93rd Edition . CRC Press, 2012, ISBN 978-1-4398-8049-4 , pp. 60 ( limited preview in Google Book search).
3. ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
4. ↑ Thomas Geschwinde: Drugs market forms and modes of action . Springer-Verlag, 2013, ISBN 978-3-662-09677-2 , pp. 531 ( limited preview in Google Book search).

This article is about a health issue. It is not used for self-diagnosis and does not replace a diagnosis by a doctor. Please note the information on health issues !